Related Experiment Video
Updated: Aug 7, 2026

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
Tobacco-specific nitrosamines in new tobacco products
Irina Stepanov1, Joni Jensen, Dorothy Hatsukami
1The Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Abstract:
New tobacco products, designed to attract consumers who are concerned about the health effects of tobacco, have been appearing on the market. Objective evaluation of these products requires, as a first step, data on their potentially toxic constituents. Tobacco-specific nitrosamines (TSNAs) are an important class of carcinogens in tobacco products, but virtually no data were available on their levels in these products. In the present study, we analyzed several new products-Ariva, Stonewall, Exalt, Revel, Smokey Mountain, and Quest-for TSNAs and compared their TSNA levels with those in nicotine replacement products and conventional smokeless tobacco and cigarette brands. TSNAs were not detected in Smokey Mountain, which is a tobacco-free snuff product. The lowest levels among the new products containing tobacco were in Ariva and Stonewall (0.26-0.28 microg/g wet weight of product). The highest levels in the new products were found in Exalt (3.3 microg/g tobacco), whereas Revel and Quest had intermediate amounts. Only trace amounts were found in nicotine replacement products, and conventional brands had levels consistent with those reported in the literature. These results demonstrate that TSNA levels in new tobacco products range from relatively low to comparable with those found in some conventional brands.
Insights
New tobacco products contain varying levels of toxic tobacco-specific nitrosamines (TSNAs). Researchers analyzed TSNAs in novel tobacco products, finding levels from none to comparable with conventional brands.
Area of Science:
- Analytical Chemistry
- Toxicology
- Public Health
Background:
- Emerging tobacco products target health-conscious consumers.
- Assessing toxicity requires data on harmful constituents like tobacco-specific nitrosamines (TSNAs).
- Limited data exists on TSNA levels in novel tobacco products.
Purpose of the Study:
- Quantify TSNA levels in new tobacco products.
- Compare TSNA content with conventional tobacco and nicotine replacement products.
Main Methods:
- Analysis of TSNAs in Ariva, Stonewall, Exalt, Revel, Smokey Mountain, and Quest.
- Comparative analysis with nicotine replacement products and traditional tobacco brands.
Main Results:
- Smokey Mountain (tobacco-free) had no detectable TSNAs.
- Ariva and Stonewall showed the lowest TSNA levels (0.26-0.28 microg/g).
- Exalt had the highest TSNA levels (3.3 microg/g), with Revel and Quest intermediate.
Conclusions:
- TSNA levels in new tobacco products vary significantly.
- Some new products contain TSNAs comparable to conventional tobacco brands.
- Further research is needed to evaluate the health implications of these TSNA levels.
More Related Videos
09:25Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
2° Amines to N-Nitrosamines: Reaction with NaNO2
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Physical Properties of Amines
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Mutagenicity and Carcinogenicity